Leiden University Medical Center
Leiden, Netherlands
41 recruiting
Showing 1–20 of 106 trials
Recruiting
Phase 2Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Myasthenia Gravis
Janssen Research & Development, LLC12 enrolled19 locationsNCT05265273
Recruiting
Phase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled64 locationsNCT05912517
Recruiting
Low-Field MRI in Stroke Code Patients
Acute StrokeMRI Imaging
Leiden University Medical Center80 enrolled1 locationNCT07702968
Recruiting
Met Non Small Cell Cancer Registry (MOMENT)
Cancer
EMD Serono Research & Development Institute, Inc.700 enrolled66 locationsNCT05376891
Recruiting
Post-Market Clinical Follow Up Study With Navitor Valve
Aortic Stenosis
Abbott Medical Devices1,000 enrolled50 locationsNCT06008080
Recruiting
Phase 3
Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
Radiation ToxicityBrain MetastasasesHigh Grade Glioma (III or IV)+4 more
The Netherlands Cancer Institute408 enrolled6 locationsNCT06888817
Recruiting
Not Applicable
Optimized Expansion of the Implanted Transcatheter Aortic Valve
Valvular Heart DiseaseAortic Stenosis Disease
Ole De Backer1,010 enrolled17 locationsNCT07042529
Recruiting
Capturing Key MG-symptoms Using Smartphone Recordings.
FatigueMyasthenia Gravis
Leiden University Medical Center225 enrolled2 locationsNCT06743490
Recruiting
Not Applicable
Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)
comaElectrographic Status Epilepticus
University of Twente150 enrolled21 locationsNCT06549426
Recruiting
Phase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Thrombocytopenia, Neonatal Alloimmune
Janssen Research & Development, LLC50 enrolled26 locationsNCT06533098
Recruiting
Phase 1Phase 2
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Non-small Cell Lung Cancer (NSCLC)KRAS, NRAS, HRAS-mutated NSCLCKRAS G12C-mutated Solid Tumors, Lung Cancer+2 more
Revolution Medicines, Inc.616 enrolled93 locationsNCT06162221
Recruiting
Phase 2
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer
Lung Cancer - Non Small Cell SquamousLung Cancer - Non Small Cell Non-Squamous
Merus B.V.180 enrolled24 locationsNCT07353957
Recruiting
Phase 2Phase 3
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
argenx12 enrolled20 locationsNCT06392386
Recruiting
Phase 4
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting
Results of Nerve Surgery to Treat PostAmputation Pain
Amputation Neuroma
Leiden University Medical Center98 enrolled1 locationNCT07605754
Recruiting
Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo740 enrolled243 locationsNCT05215340
Recruiting
Phase 3
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Alpha1-Antitrypsin Deficiency
Takeda160 enrolled89 locationsNCT05677971
Recruiting
SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging
Vascular Disease，Peripheral
Leiden University Medical Center30 enrolled1 locationNCT07558174
Recruiting
Bleeding Disorder of Unknown Cause in the Netherlands
Hemorrhagic DisordersBleeding Disorder of Unknown Cause
Maastricht University Medical Center500 enrolled8 locationsNCT07454161
Recruiting
Phase 3
A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group
Long Term Efficacy and Safety
Hansa Biopharma AB150 enrolled14 locationsNCT05937750